DNA aptamers to human immunodeficiency virus reverse transcriptase selected by a primer-free SELEX method: Characterization and comparison with other aptamers

Nucleic Acid Therapeutics

Volumn 22, Issue 3, 2012, Pages 162-176

  Lai, Yi Tak ^a,b   DeStefano, Jeffrey J ^a  

^a Bldg 142   (United States)

^b ST MARY'S COLLEGE OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; DIADENOSINE HEXAPHOSPHATE; DNA; GUANOSINE; NUCLEOTIDE; RNA DIRECTED DNA POLYMERASE; THYMIDINE;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CIRCULAR DICHROISM; COMBINATORIAL CHEMISTRY; DISSOCIATION CONSTANT; HUMAN IMMUNODEFICIENCY VIRUS; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; SEQUENCE ANALYSIS;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CIRCULAR DICHROISM; G-QUADRUPLEXES; HIV REVERSE TRANSCRIPTASE; REVERSE TRANSCRIPTASE INHIBITORS; SELEX APTAMER TECHNIQUE; THERMODYNAMICS;

EID: 84862339398     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2011.0327     Document Type: Article

References (66)

1. ANDREOLA, M.L., PILEUR, F., CALMELS, C., VENTURA, M., TARRAGO-LITVAK, L., TOULME, J.J., and LITVAK, S. (2001). DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity. Biochemistry 40, 10087-10094.
2. BERNARDI, F., GAGGELLI, E., MOLTENI, E., PORCIATTI, E., VALENSIN, D., and VALENSIN, G. (2006). 1H and 13C-NMR and molecular dynamics studies of cyclosporin a interacting with magnesium(II) or cerium(III) in acetonitrile. Conformational changes and cis-trans conversion of peptide bonds. Biophys. J. 90, 1350-1361.
3. BOCK, L.C., GRIFFIN, L.C., LATHAM, J.A., VERMAAS, E.H., and TOOLE, J.J. (1992). Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355, 564-566.
4. BRODY, E.N., and GOLD, L. (2000). Aptamers as therapeutic and diagnostic agents. J. Biotechnol. 74, 5-13.
5. CERCHIA, L., DUCONGE, F., PESTOURIE, C., BOULAY, J., AISSOUNI, Y., GOMBERT, K., TAVITIAN, B., DE FRANCISCIS, V., and LIBRI, D. (2005). Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 3, e123.
6. COGOI, S., BALLICO, M., BONORA, G.M., and XODO, L.E. (2004a). Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding. Cancer Gene Ther. 11, 465-476.
7. COGOI, S., QUADRIFOGLIO, F., and XODO, L.E. (2004b). G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells. Biochemistry 43, 2512-2523.
8. CREIGHTON, S., HUANG, S.M., CAI, H., ARNHEIM, N., and GOODMAN, N.F. (1992). Base mispair extension kinetics. J. Biol. Chem. 267, 2633-2639.
9. DAPAS, B., TELL, G., SCALONI, A., PINES, A., FERRARA, L., QUADRIFOGLIO, F., and SCAGGIANTE, B. (2003). Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers. Eur. J. Biochem. 270, 3251-3262.
10. DE SOULTRAIT, V.R., LOZACH, P.Y., ALTMEYER, R., TARRAGO-LITVAK, L., LITVAK, S., and ANDREOLA, M.L. (2002). DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents. J. Mol. Biol. 324, 195-203.
11. DEISINGH, A.K. (2006). Aptamer-based biosensors: biomedical applications. Handb. Exp. Pharmacol., 341-357.
12. DEMPSEY, L.A., SUN, H., HANAKAHI, L.A., and MAIZELS, N. (1999). G4 DNA binding by LR1 and its subunits, nucleolin and hnRNP D, A role for G-G pairing in immunoglobulin switch recombination. J. Biol. Chem. 274, 1066-1071.
13. DESTEFANO, J.J., and CRISTOFARO, J.V. (2006). Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity. Nucleic Acids Res. 34, 130-139.
14. DESTEFANO, J.J., and NAIR, G.R. (2008). Novel aptamer inhibitors of human immunodeficiency virus reverse transcriptase. Oligonucleotides 18, 133-144.
15. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
16. GOLD, L. (1995). The SELEX process: a surprising source of therapeutic and diagnostic compounds. Harvey Lect. 91, 47-57.
17. GONZALEZ, V., and HURLEY, L.H. (2010). The c-MYC NHE III(1): function and regulation. Annu. Rev. Pharmacol. Toxicol. 50, 111-129.
18. GOODCHILD, A., KING, A., GOZAR, M.M., PASSIOURA, T., TUCKER, C., and RIVORY, L. (2007). Cytotoxic G-rich oligodeoxynucleotides: putative protein targets and required sequence motif. Nucleic Acids Res. 35, 4562-4572.
19. HALL, K.B., and KRANZ, J.K. (1999). Nitrocellulose filter binding for determination of dissociation constants. In RNA-protein interaction protocols. Haynes, S.R., ed. (Humana Press, Totowa, New Jersey). pp. 105-128.
20. HANAKAHI, L.A., SUN, H., and MAIZELS, N. (1999). High affinity interactions of nucleolin with G-G-paired rDNA. J. Biol. Chem. 274, 15908-15912.
21. HERSHMAN, S.G., CHEN, Q., LEE, J.Y., KOZAK, M.L., YUE, P., WANG, L.S., and JOHNSON, F.B. (2008). Genomic distribution and functional analyses of potential G-quadruplex-forming sequences in Saccharomyces cerevisiae. Nucleic Acids Res. 36, 144-156.
22. HICKE, B.J., MARION, C., CHANG, Y.F., GOULD, T., LYNOTT, C.K., PARMA, D., SCHMIDT, P.G., and WARREN, S. (2001). Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem. 276, 48644-48654.
23. HICKE, B.J., STEPHENS, A.W., GOULD, T., CHANG, Y.F., LYNOTT, C.K., HEIL, J., BORKOWSKI, S., HILGER, C.S., COOK, G., WARREN, S., and SCHMIDT, P.G. (2006). Tumor targeting by an aptamer. J. Nucl. Med. 47, 668-678.
24. HORNUNG, V., and LATZ, E. (2010). Intracellular DNA recognition. Nat. Rev. Immunol. 10, 123-130.
25. HOTODA, H., KOIZUMI, M., KOGA, R., KANEKO, M., MOMOTA, K., OHMINE, T., FURUKAWA, H., AGATSUMA, T., NISHIGAKI, T., et al. (1998). Biologically active oligodeoxyribonucleotides. 5. 5′-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure. J. Med. Chem. 41, 3655-3663.
26. HSIEH, J.C., ZINNEN, S., and MODRICH, P. (1993). Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 268, 24607-24613.
27. HUNG, S.H., YU, Q., GRAY, D.M., and RATLIFF, R.L. (1994). Evidence from CD spectra that d(purine).r(pyrimidine) and r(purine).d(pyrimidine) hybrids are in different structural classes. Nucleic Acids Res. 22, 4326-4334.
28. JAMES, W. (2007). Aptamers in the virologists' toolkit. J. Gen. Virol. 88, 351-364.
29. JAROSCH, F., BUCHNER, K., and KLUSSMANN, S. (2006). In vitro selection using a dual RNA library that allows primerless selection. Nucleic Acids Res. 34, e86.
30. JOSHI, P.J., FISHER, T.S., and PRASAD, V.R. (2003). Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent antivirals. Curr. Drug Targets Infect. Disord. 3, 383-400.
31. JOYCE, G.F. (1989). Amplification, mutation, and selection of catalytic RNA. Gene 82, 83-87.
32. KELLEY, S., BORODA, S., MUSIER-FORSYTH, K., and KANKIA, B.I. (2011). HIV-integrase aptamer folds into a parallel quadruplex: a thermodynamic study. Biophys. Chem. 155, 82-88.
33. KENSCH, O., CONNOLLY, B.A., STEINHOFF, H.J., MCGREGOR, A., GOODY, R.S., and RESTLE, T. (2000). HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding affinity in the low picomolar range coupled with high specificity. J. Biol. Chem. 275, 18271-18278.
34. KISSEL, J.D., HELD, D.M., HARDY, R.W., and BURKE, D.H. (2007). Active site binding and sequence requirements for inhibition of HIV-1 reverse transcriptase by the RT1 family of single-stranded DNA aptamers. Nucleic Acids Res. 35, 5039-5050.
35. KYPR, J., KEJNOVSKA, I., RENCIUK, D., and VORLICKOVA, M. (2009). Circular dichroism and conformational polymorphism of DNA. Nucleic Acids Res. 37, 1713-1725.
36. LAI, Y.T., and DESTEFANO, J.J. (2011). A primer-free method that selects high-affinity single-stranded DNA aptamers using thermostable RNA ligase. Anal. Biochem. 414, 246-253.
37. LANG, W., PERKINS, H., ANDERSON, R.E., ROYCE, R., JEWELL, N., and WINKELSTEIN, W., JR. (1989). Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J. Acquir. Immune Defic. Syndr. 2, 63-69.
38. MACAYA, R.F., SCHULTZE, P., SMITH, F.W., ROE, J.A., and FEIGON, J. (1993). Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc. Natl. Acad. Sci. U. S. A. 90, 3745-3749.
39. MICHALOWSKI, D., CHITIMA-MATSIGA, R., HELD, D.M., and BURKE, D.H. (2008). Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptases. Nucleic Acids Res. 36, 7124-7135.
40. MISSAILIDIS, S., and PERKINS, A. (2007). Update: aptamers as novel radiopharmaceuticals: their applications and future prospects in diagnosis and therapy. Cancer Biother. Radiopharm. 22, 453-468.
41. MOK, W., and LI, Y. (2008). Recent progress in nucleic acid aptamer-based biosensors and bioassays. Sensors 8, 7050-7084.
42. MOSING, R.K., MENDONSA, S.D., and BOWSER, M.T. (2005). Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal. Chem. 77, 6107-6112.
43. NIMJEE, S.M., RUSCONI, C.P., and SULLENGER, B.A. (2005). Aptamers: an emerging class of therapeutics. Annu. Rev. Med. 56, 555-583.
44. PAN, W., and CLAWSON, G.A. (2010) Primer-free aptamer selection using a random DNA library. Methods Mol. Biol. 629, 369-385.
45. PAN, W., XIN, P., and CLAWSON, G.A. (2008). Minimal primer and primer-free SELEX protocols for selection of aptamers from random DNA libraries. BioTechniques 44, 351-360.
46. PIEVE, C.D., PERKINS, A.C., and MISSAILIDIS, S. (2009). Anti-MUC1 aptamers: radiolabelling with (99m)Tc and biodistribution in MCF-7 tumour-bearing mice. Nucl. Med. Biol. 36, 703-710.
47. PORSCHEWSKI, P., GRATTINGER, M.A., KLENZKE, K., ERPENBACH, A., BLIND, M.R., and SCHAFER, F. (2006). Using aptamers as capture reagents in bead-based assay systems for diagnostics and hit identification. J. Biomol. Screen. 11, 773-781.
48. RIOU, J.F., GUITTAT, L., MAILLIET, P., LAOUI, A., RENOU, E., PETITGENET, O., MEGNIN-CHANET, F., HELENE, C., and MERGNY, J.L. (2002). Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc. Natl. Acad. Sci. U. S. A. 99, 2672-2677.
49. RISITANO, A., and FOX, K.R. (2004). Influence of loop size on the stability of intramolecular DNA quadruplexes. Nucleic Acids Res. 32, 2598-2606.
50. SAMBROOK, J., and RUSSELL, D.W. (2001). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York). pp. 5.40-5.46, 12.74, 12.78.
51. SCAGGIANTE, B., MORASSUTTI, C., DAPAS, B., TOLAZZI, G., USTULIN, F., and QUADRIFOGLIO, F. (1998). Human cancer cell lines growth inhibition by GTn oligodeoxyribonucleotides recognizing single-stranded DNA-binding proteins. Eur. J. Biochem. 252, 207-215.
52. SCHNEIDER, D.J., FEIGON, J., HOSTOMSKY, Z., and GOLD, L. (1995). High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 34, 9599-9610.
53. SIMONSSON, T. (2001). G-quadruplex DNA structures: variations on a theme. Biol. Chem. 382, 621-628.
54. SISSI, C., GATTO, B., and PALUMBO, M. (2011). The evolving world of protein-G-quadruplex recognition: a medicinal chemist's perspective. Biochimie 93, 1219-1230.
55. TANG, Z., SHANGGUAN, D., WANG, K., SHI, H., SEFAH, K., MALLIKRATCHY, P., CHEN, H.W., LI, Y., and TAN, W. (2007). Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem. 79, 4900-4907.
56. TOHL, J., and EIMER, W. (1997). Interaction of a G-DNA quadruplex with mono- and divalent cations. A force field calculation. Biophys. Chem. 67, 177-186.
57. TONG, W., LU, C.-D., SHARMA, S.K., MATSUURA, S., SO, A.G., and SCOTT, W.A. (1997). Nucleotide-Induced Stable Complex Formation by HIV-1 Reverse Transcriptase. Biochemistry 36, 5749-5757.
58. TUERK, C., and GOLD, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.
59. TUERK, C., MACDOUGAL, S., and GOLD, L. (1992). RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U. S. A. 89, 6988-6992.
60. VATER, A., and KLUSSMANN, S. (2003). Toward third-generation aptamers: Spiegelmers and their therapeutic prospects. Curr. Opin. Drug Discov. Devel. 6, 253-261.
61. WANG, J., JIANG, H., and LIU, F. (2000). In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection. RNA 6, 571-583.
62. WEN, J.D., and GRAY, D.M. (2004). Ff gene 5 single-stranded DNA-binding protein assembles on nucleotides constrained by a DNA hairpin. Biochemistry 43, 2622-2634.
63. WOLINSKY, S.M., KORBER, B.T., NEUMANN, A.U., DANIELS, M., KUNSTMAN, K.J., WHETSELL, A.J., FURTADO, M.R., CAO, Y., HO, D.D., and SAFRIT, J.T. (1996). Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection [see comments]. Science 272, 537-542.
64. ZHANG, Z., BLANK, M., and SCHLUESENER, H.J. (2004). Nucleic acid aptamers in human viral disease. Arch. Immunol. Ther. Exp. (Warsz) 52, 307-315.
65. ZHU, T., COREY, L., HWANGBO, Y., LEE, J.M., LEARN, G.H., MULLINS, J.I., and MCELRATH, M.J. (2003). Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J. Virol. 77, 6108-6116.
66. ZUKER, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415.